An Inhibitor of Casein Kinase Iϵ Induces Phase Delays in Circadian Rhythms under Free-Running and Entrained Conditions

Casein kinase Iϵ (CKIϵ) is an essential component of the biological clock, phosphorylating PER proteins, and in doing so regulating their turnover and nuclear entry in oscillator cells of the suprachiasmatic nucleus (SCN). Although hereditary decreases in PER phosphorylation have been well characterized, little is known about the consequences of acute enzyme inhibition by pharmacological means. A novel reagent, 4-[3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamine (PF-670462), proved to be both a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CKIϵ in isolated enzyme preparations; in transfected whole cell assays, it caused a concentration-related redistribution of nuclear versus cytosolic PER. When tested in free-running animals, 50 mg/kg s.c. PF-670462 produced robust phase delays when dosed at circadian time (CT)9 (–1.97 ± 0.17 h). Entrained rats dosed in normal light-dark (LD) and then released to constant darkness also experienced phase delays that were dose- and time of dosing-dependent. PF-670462 yielded only phase delays across the circadian cycle with the most sensitive time at CT12 when PER levels are near their peak in the SCN. Most importantly, these drug-induced phase delays persisted in animals entrained and maintained in LD throughout the entire experiment; re-entrainment to the prevailing LD required days in contrast to the rapid elimination of the drug (t1/2 = 0.46 ± 0.04 h). Together, these results suggest that inhibition of CKIϵ yields a perturbation of oscillator function that forestalls light as a zeitgeber, and they demonstrate that pharmacological tools such as PF-670462 may yield valuable insight into clock function.

[1]  Ying Xu,et al.  Functional consequences of a CKIδ mutation causing familial advanced sleep phase syndrome , 2005, Nature.

[2]  Andreas Gocht,et al.  The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. , 2005, Cellular signalling.

[3]  E. Maywood,et al.  Analysis of Clock Proteins in Mouse SCN Demonstrates Phylogenetic Divergence of the Circadian Clockwork and Resetting Mechanisms , 2000, Neuron.

[4]  E. Maywood,et al.  Differential Regulation of mPER1 and mTIM Proteins in the Mouse Suprachiasmatic Nuclei: New Insights into a Core Clock Mechanism , 1999, The Journal of Neuroscience.

[5]  Peter Woolf,et al.  Control of Mammalian Circadian Rhythm by CKIε-Regulated Proteasome-Mediated PER2 Degradation , 2005, Molecular and Cellular Biology.

[6]  Zheng Chen,et al.  The right place at the right time: regulation of daily timing by phosphorylation. , 2006, Genes & development.

[7]  M. Hagiwara,et al.  A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide, and affinity purification of casein kinase I from bovine testis. , 1989, The Journal of biological chemistry.

[8]  G. Cahill,et al.  Regulation of the Circadian Oscillator in Xenopus Retinal Photoreceptors by Protein Kinases Sensitive to the Stress-activated Protein Kinase Inhibitor, SB 203580* , 2004, Journal of Biological Chemistry.

[9]  J. Sprouse Pharmacological modulation of circadian rhythms: a new drug target in psychotherapeutics , 2004, Expert opinion on therapeutic targets.

[10]  E. Eide,et al.  Nuclear Entry of the Circadian Regulator mPER1 Is Controlled by Mammalian Casein Kinase I ɛ , 2000, Molecular and Cellular Biology.

[11]  U. Schibler Circadian time keeping: the daily ups and downs of genes, cells, and organisms. , 2006, Progress in brain research.

[12]  E. Nishida,et al.  Control of Intracellular Dynamics of Mammalian Period Proteins by Casein Kinase I ε (CKIε) and CKIδ in Cultured Cells , 2002, Molecular and Cellular Biology.

[13]  Christopher R. Jones,et al.  An hPer2 Phosphorylation Site Mutation in Familial Advanced Sleep Phase Syndrome , 2001, Science.

[14]  W. Bunney,et al.  Molecular Clock Genes in Man and Lower Animals: Possible Implications for Circadian Abnormalities in Depression , 2000, Neuropsychopharmacology.

[15]  Bentham Science Publisher J.P. Wisor Disorders of the circadian clock: etiology and possible therapeutic targets. , 2002, Current Drug Targets - CNS & Neurological Disorders.

[16]  M. Stöter,et al.  IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects , 2000, Oncogene.

[17]  T. Nagase,et al.  Phosphorylation of clock protein PER1 regulates its circadian degradation in normal human fibroblasts. , 2004, The Biochemical journal.

[18]  P. Graves,et al.  Phosphate groups as substrate determinants for casein kinase I action. , 1990, The Journal of biological chemistry.

[19]  Rajanikanth Vadigepalli,et al.  Epidermal growth factor receptor-induced circadian-time-dependent gene regulation in suprachiasmatic nucleus , 2006, Neuroreport.

[20]  D. Boivin,et al.  A molecular perspective of human circadian rhythm disorders , 2003, Brain Research Reviews.

[21]  C. Weitz,et al.  Light-independent role of CRY1 and CRY2 in the mammalian circadian clock. , 1999, Science.

[22]  J. Takahashi,et al.  Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. , 2000, Science.

[23]  Steven M Reppert,et al.  mCRY1 and mCRY2 Are Essential Components of the Negative Limb of the Circadian Clock Feedback Loop , 1999, Cell.

[24]  S. Peirson,et al.  Comparison of clock gene expression in SCN, retina, heart, and liver of mice. , 2006, Biochemical and biophysical research communications.

[25]  E. Eide,et al.  CASEIN KINASE I: ANOTHER COG IN THE CIRCADIAN CLOCKWORKS , 2001, Chronobiology international.

[26]  P. Cohen,et al.  D4476, a cell‐permeant inhibitor of CK1, suppresses the site‐specific phosphorylation and nuclear exclusion of FOXO1a , 2004, EMBO reports.

[27]  A. Balsalobre,et al.  Clock genes in mammalian peripheral tissues , 2002, Cell and Tissue Research.

[28]  Rae Silver,et al.  Orchestrating time: arrangements of the brain circadian clock , 2005, Trends in Neurosciences.

[29]  S. Reppert,et al.  Molecular analysis of mammalian circadian rhythms. , 2001, Annual review of physiology.

[30]  Daniel B. Forger,et al.  An opposite role for tau in circadian rhythms revealed by mathematical modeling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Coogan,et al.  MAP kinases in the mammalian circadian system – key regulators of clock function , 2004, Journal of neurochemistry.

[32]  Steven M. Reppert,et al.  Posttranslational Mechanisms Regulate the Mammalian Circadian Clock , 2001, Cell.

[33]  E. Eide,et al.  The Circadian Regulatory Proteins BMAL1 and Cryptochromes Are Substrates of Casein Kinase Iε* , 2002, The Journal of Biological Chemistry.